A MATCHING-ADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF BIMEKIZUMAB AND SECUKINUMAB AT 52 WEEKS FOR THE TREATMENT OF PSORIATIC ARTHRITIS

被引：0
|
作者：
Mease, P. J. [1 ,2 ]
Warren, R. B. [3 ]
Nash, P. [4 ]
Grouin, J. M. [5 ]
Willems, D. [6 ]
Taieb, V [7 ]
Eells, J. [8 ]
McInnes, I. [9 ]
机构：
[1] Univ Washington, Swedish Med Ctr, Seattle, WA USA
[2] Univ Washington, Providence St Joseph Hlth, Seattle, WA USA
[3] Northern Care Alliance NHS Fdn Trust, Dermatol Ctr, Manchester, Lancs, England
[4] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England
[5] Univ Rouin, Rouen, Normandy, France
[6] UCB Pharma, Brussels, Belgium
[7] UCB Pharma, Colombes, France
[8] UCB Pharma, Slough, Berks, England
[9] Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO10
引用
收藏
页码：S16 / S16
页数：1
相关论文
共 50 条
  • [21] MATCHING-ADJUSTED INDIRECT COMPARISON OF IXEKIZUMAB VS. TOFACITINIB IN PSORIATIC ARTHRITIS
    Sapin, C.
    Panni, T.
    Meszaros, G.
    Hill, J.
    Hartz, S.
    VALUE IN HEALTH, 2020, 23 : S593 - S593
  • [22] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison (vol 5, pg 99, 2018)
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Thom, Howard
    Hunger, Matthias
    Karabis, Andreas
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen M.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (02) : 595 - 595
  • [23] RELATIVE EFFICACY OF ADALIMUMAB VERSUS SECUKINUMAB IN ACTIVE ANKYLOSING SPONDYLITIS: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Betts, K. A.
    Mittal, M.
    Song, J.
    Skup, M.
    Joshi, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 98 - 99
  • [24] A COST PER RESPONDER ANALYSIS OF SECUKINUMAB VS. ADALIMUMAB BASED ON A MATCHING-ADJUSTED INDIRECT COMPARISON OF EFFICACY DATA FOR THE TREATMETN OF PSORIATIC ARTHRITIS AT 48 WEEKS FROM THE IRISH PAYER PERSPECTIVE
    Gunda, P.
    Nikoglou, E.
    Jugl, S. M.
    Murphy, A.
    VALUE IN HEALTH, 2017, 20 (09) : A532 - A532
  • [25] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND INFLIXIMAB IN PSORIATIC ARTHRITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA
    Kaul, Arvind
    Strand, Vibeke
    McInnes, Lain
    Mease, Philip
    Choy, Ernest
    Nash, Peter
    Thom, Howard
    Kalyvas, Chrysostomos
    Gandhi, Kunal
    Pricop, Luminita
    Jugl, Steffen
    RHEUMATOLOGY, 2018, 57
  • [26] COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND INFLIXIMAB IN PSORIATIC ARTHRITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE 3 CLINICAL TRIAL DATA
    Strand, V.
    McInnes, I.
    Mease, P.
    Choy, E.
    Nash, P.
    Thom, H.
    Kalyvas, C.
    Gandhi, K.
    Pricop, L.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 957 - 957
  • [27] A COST PER RESPONDER ANALYSIS OF SECUKINUMAB VS. ADALIMUMAB BASED ON A MATCHING-ADJUSTED INDIRECT COMPARISON OF EFFICACY DATA FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS AT 52 WEEKS FROM THE IRISH PAYER PERSPECTIVE
    Gunda, P.
    Nikoglou, E.
    Jugl, S. M.
    Murphy, A.
    VALUE IN HEALTH, 2017, 20 (09) : A533 - A533
  • [28] SECUKINUMAB PROVIDES HIGHER SYMPTOMATIC IMPROVEMENT VERSUS ADALIMUMAB IN PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS UP TO 48 WEEKS ASSESSED BY TWO MATCHING-ADJUSTED INDIRECT COMPARISONS
    Thom, H.
    Hunger, M.
    Rosal, G. F.
    Gandhi, K.
    Jugl, S. M.
    Nash, P.
    VALUE IN HEALTH, 2017, 20 (09) : A935 - A935
  • [29] Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison
    Maksymowych, Walter P.
    Strand, Vibeke
    Nash, Peter
    Yazici, Yusuf
    Thom, Howard
    Hunger, Matthias
    Kalyvas, Chrysostomos
    Gandhi, Kunal K.
    Porter, Brian
    Jugl, Steffen M.
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2018, 5 (04) : 216 - +
  • [30] SECUKINUMAB FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Maksymowych, W.
    Strand, V
    Baeten, D.
    Nash, P.
    Thom, H.
    Hunger, M.
    Gandhi, K.
    Richards, H.
    Jugl, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 782 - 782
12345